Every day from 9:00 a.m. to 6.00 p.m. (time zone UTC+3 MSK)
Authorized Representative (AR) Services for Medical Devices in Russia & EAEU
Our manager will email you
The Authorized Representative in Russia is a legal entity or an individual entrepreneur who is a resident of the Russian Federation. They are formally empowered by the foreign manufacturer to represent its interests regarding all matters of the device’s circulation in Russia, including conformity assessment and state registration procedures with Roszdravnadzor.
The Authorized Representative within the EAEU is a legal entity or an individual entrepreneur who is a resident of a member state. They are authorized by the manufacturer via a contract or other legally recognized document to represent its interests and bear legal responsibility for the device’s circulation within the Union and for ensuring compliance with all mandatory requirements.
The Authorized Representative ensures compliance with the legal framework for medical devices, which includes:
Regulatory Liaison: Official communication with Roszdravnadzor and other regulatory bodies (EAEU);
Post-Market Compliance: Handling control procedures, safety monitoring, and clinical trial oversight.
Key Terminology for Representing Foreign Medical Device Manufacturers in Russia/EAEU:
AR: The Authorized Representative of the Medical Device Manufacturer (Producer);
Medical Device Registration: A mandatory procedure to confirm a medical device’s quality, efficacy, and safety, granting the legal right to market it in Russia or EAEU member states;
Federal Service for Surveillance in Healthcare (Roszdravnadzor): The federal executive body responsible for control and supervision in the field of healthcare in Russia, including medical device regulation;
Registration Dossier: The complete set of documents submitted by an applicant for state registration of a medical device, amendments to it, or its cancellation. It includes copies of all decisions made by the registering authority and its expert institution;
Falsified Medical Device: A medical device accompanied by false information about its characteristics and/or its manufacturer (producer);
Substandard Medical Device: A medical device that fails to meet the safety and efficacy requirements, labelling requirements, regulatory, technical, and operational documentation requirements and cannot be used safely for its intended purpose established by the manufacturer (producer);
Counterfeit Medical Device: A medical device circulated in violation of civil legislation;
Adverse Event (Incident): Any malfunction and/or deterioration in characteristics, or disruption of the functioning of a medical device, or insufficiency or inaccuracy of the accompanying information (documentation) for a medical device, or adverse reaction not specified in the instructions for use, which directly or indirectly led or could have led to death or serious deterioration in the health of users or third parties (hereinafter, serious deterioration in health is understood to mean a life-threatening disease, persistent impairment of body function or irreversible damage to body structure, a condition requiring medical or surgical intervention to prevent a life-threatening disease, or persistent impairment of body function, or irreversible damage to body structure, a condition requiring hospitalization or a significant increase in the length of hospital stay of an already hospitalized patient, functional impairment in the fetus, its death, congenital anomaly or birth injury);
Undesirable Event: Any unforeseen medical occurrence, illness, injury, or undesirable clinical sign (including abnormal lab findings) in a user or third party associated with the use of a medical device.
Important Note: The scope of services of the authorized representative of the manufacturer depends on the class of potential risk of using the medical device.
Services of an Authorized Representative (AR):
Service Description
Included in Retainer
Available for Additional Fee
Secure storage of the medical device’s Technical Documentation, complete Registration Dossier, and related archives
V
X
Tracking validity periods of registration dossier documents, other information related to the MD and developing an optimal plan for updating the registration dossier if necessary
V
X
Notification to Roszdravnadzor of each imported medical device batch (per Order No. 11020 of November 25, 2021)
X
V
Storage of finished products (MD) prior to sale
X
V
Ensuring compliant transportation conditions within Russia/EAEU to preserve manufacturer’s product quality
X
V
Searching for potential distributors within Russia/EAEU
X
V
Representing the manufacturer’s interests in Russia/EAEU before regulatory authorities regarding any inquiries about the medical device’s quality, efficacy, safety, and compliance
V
X
Providing information to consumers regarding the technical and operational properties of the medical device, and addressing consumer inquiries about the device (up to 7 responses per month; additional responses beyond 7 are subject to a supplementary fee of $100 per response)
V
V
Informing the manufacturer of relevant changes to Russian/EAEU standards and legislation applicable to the medical device
V
X
Submission to Roszdravnadzor of the annual report on post-registration clinical monitoring of safety and efficacy of risk class 3 medical devices and class 2b implantable medical devices, in accordance with Order of the Ministry of Health No. 1113n of October 19, 2020, or EEC Board Decision No. 174 of December 22, 2015
V
X
Finding a licensed maintenance service company in Russia/EAEU, if required
X
V
Representing the manufacturer in the event of and during adverse event (incident) investigations related to the operation/use of the medical device (no more than 12 incidents or notifications to competent authorities per year; a supplementary fee of $220 will be charged for each additional incident or notification exceeding 12)
V
V
Representation of the manufacturer’s interests during the implementation of corrective actions in case of adverse events related to the circulation of MD in Russia/EAEU: development of a corrective action program, safety notices
V
X
Participation in the procedure for recalling a medical device from the market based on the decision of regulatory authorities or the manufacturer
V
X
Representing the manufacturer during destruction or disposal of medical devices
V
X
Representing the manufacturer during registration dossier amendments (VIRD), with a 15% discount if the full procedure is conducted by NEEDFORMED LLC
V
V
Representing the manufacturer during new device registration, with a 15% discount if the full procedure is conducted by NEEDFORMED LLC
V
V
Work Stages
Contract Execution: Formalizing the agreement and defining the scope of representation
AR Registry Entry Update: Officially updating the registration dossier to list our company as your Authorized Representative (AR) in the registry
Regulatory Liaison: Serving as your primary point of contact and managing all official communications with Roszdravnadzor and other regulatory bodies
Documentation Custody: Secure storage of your device’s technical documentation, registration dossier, and all related archives
Dossier Validity Tracking & Planning: Monitoring of document expiration dates and formulation of an optimal plan for timely registration dossier amendments (VIRD), if necessary
Compliance & Surveillance Management: Handling all activities related to state market surveillance, post-market safety monitoring (PMS), and clinical follow-up (PMCF)
Regulatory Change Alerts: Keeping the manufacturer apprised of all relevant updates to Russian and EAEU standards and legislation affecting the device
Complaint & Incident Investigation: Managing the formal investigation of complaints and adverse incidents
Terms for Authorized Representative (AR) Services:
The minimum contract term for Authorized Representative services is 12 months.
Pricing for Authorized Representative (AR) Services (Monthly Retainer Fee Based on Device Risk Class):
Risk Class 1
from $245
Risk Class 2a
from $490
Risk Class 2b
from $735
Risk Class 3
from $980
Pricing for Additional Authorized Representative (AR) Services:
Services related to the import of registered medical devices into Russia/EAEU
Price upon request
Storage of finished products (MD) prior to sale
Price upon request
Ensuring compliant transportation conditions within Russia/EAEU to preserve manufacturer’s product quality
Price upon request
Searching for potential distributors within Russia/EAEU
Price upon request
Providing information to consumers regarding the technical and operational properties of the medical device, and addressing consumer inquiries about the device (beyond the 7 monthly responses included in the retainer)
$100 per response
Finding a licensed maintenance service company in Russia/EAEU, if required
Price upon request
Representing the manufacturer in the event of and during adverse event (incident) investigations related to the operation/use of the medical device (beyond the 12 annual cases included in the retainer)
from $220 per incident (or notification)
Core Regulatory Framework for Authorized Representative (AR) Services:
Federal Law No. 323-FZ of November 21, 2011 “On the Fundamentals of Health Protection of Citizens in the Russian Federation”;
Federal Law No. 294-FZ of December 26, 2008 “On the Protection of the Rights of Legal Entities and Individual Entrepreneurs in the Exercise of State Control (Supervision) and Municipal Control”;
Government Resolution No. 1684 of November 30 2024, “On Approval of the Rules for State Registration of Medical Devices”;
Government Resolution No. 1066 of June 30, 2021 “On Federal State Control (Supervision) over the Circulation of Medical Devices”;
Government Resolution No. 145 of February 10, 2022 “On Approval of the Rules for Withdrawal from Circulation and Destruction of Counterfeit, Substandard, and Falsified Medical Devices”;
Order of the Ministry of Health No. 980n of September 15, 2020 “On Approval of the Procedure for Monitoring the Safety of Medical Devices”;
Order of the Ministry of Health No. 1113n of October 19, 2020 “On Approval of the Procedure for Notifying Entities Circulating Medical Devices of All Cases of Adverse Events Not Specified in the Instructions for Use or Operating Manual for a Medical Device, Adverse Reactions During Its Use, Interactions Between Medical Devices, and Facts and Circumstances Possibly Threating the Life and Health of Citizens and Healthcare Workers During the Use and Operation of Medical Devices”;
Order of Roszdravnadzor No. 11020 of November 25, 2021 “On Approval of the Procedure for Submission by the Manufacturer (Producer) of a Medical Device (their Authorized Representative) or by a Person Importing Medical Devices into the Russian Federation of Information to the Authorized Federal Executive Body Exercising Functions on Control and Supervision in the Sphere of Healthcare”;
Guideline on Compliance with Mandatory Requirements in the Field of Medical Device Circulation of November 14, 2022;
Order of the Ministry of Health No. 201n of May 2, 2023 “On Approval of the Procedure for Importing Medical Devices into the Territory of the Russian Federation for the Purpose of State Registration”;
Order of the Ministry of Health No. 368n of July 17, 2023 “On Approval of Risk Indicators for Violation of Mandatory Requirements Used by the Federal Service for Surveillance in Healthcare in the Implementation of Federal State Control (Supervision) over the Circulation of Medical Devices”;
Order of Roszdravnadzor No. 4513 of May 20, 2021 “On Approval of the Classification of Adverse Events Related to the Circulation of Medical Devices”;
Order of Roszdravnadzor No. 1 of January 10, 2022 “On Approval of Checklist Forms (Lists of Checklist Questions, the Answers to Which Indicate Compliance or Non-Compliance with Mandatory Requirements by the Supervised Entity) Used by the Federal Service for Surveillance in Healthcare and Its Territorial Bodies in the Implementation of Federal State Control (Supervision) over the Circulation of Medical Devices”;
EEC Council Decision No. 130 of November 12, 2021 “On the Procedure for Importing Products Subject to Mandatory Conformity Assessment into the Customs Territory of the Eurasian Economic Union”;
EEC Council Decision No. 141 of December 21, 2016 “On Approval of the Procedure for the Application by Authorized Bodies of the Eurasian Economic Union Member States of Measures to Suspend or Prohibit the Use of Medical Devices That Possess a Danger to Human Life and/or Health, Substandard, Counterfeit, or Falsified Medical Devices, and to Withdraw Them from Circulation in the Territories of the Eurasian Economic Union Member States”;
EEC Board Decision No. 174 of December 22, 2015 “On Approval of the Rules for Monitoring Safety, Quality and Efficacy of Medical Devices”.
Schedule Your Free Consultation
Our specialist will contact you at your convenience
NEEDFORMED LLC uses cookies to improve the usability of the website.
By continuing to use our website, you consent to the use of cookies.
Read our Cookie policy. If you do not want
to use cookies, please change your browser settings.